Skip to main content
. 2021 Feb 9;40(Iss 2 Suppl 1):S102–S110. doi: 10.1097/PGP.0000000000000755

TABLE 1.

Summary of main prognostic/predictive biomarkers in cervical adenocarcinoma

Biomarker Predictive/prognostic Target Evidence
BCAR4 amplification Predictive HER2 Low
KRAS mutation Prognostic KRAS Strong
HER2 amplification Predictive/prognostic HER2 Moderate
HER2 mutation Predictive HER2 Strong
PDL-1 expression Predictive/prognostic Immune checkpoint inhibition Moderate